6533b7ddfe1ef96bd1275251

RESEARCH PRODUCT

Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: A commentary

Federica MacalusoG. GugginoF. Ciccia

subject

Multiple SclerosisRheumatologyAntirheumatic AgentsMultiple SclerosiImmunologyAntirheumatic AgentHumansImmunology and AllergySpondylitis AnkylosingAntibodies Monoclonal HumanizedHuman

description

No abstract available

http://www.scopus.com/inward/record.url?eid=2-s2.0-85102090773&partnerID=MN8TOARS